147663-00-1 Usage
Uses
Used in Pharmaceutical Industry:
3,4-Dihydro-1H-isochromen-4-amine hydrochloride is used as a reactant for the preparation of isochromanamine derivatives and analogs, which are known to have potential applications as nervous system agents. These derivatives are being investigated for their effects on neurological disorders and conditions, such as anxiety, depression, and cognitive impairments.
Used in Chemical Research:
In addition to its pharmaceutical applications, 3,4-dihydro-1H-isochromen-4-amine hydrochloride is also utilized in chemical research as a starting material for the synthesis of various organic compounds. Its unique chemical structure allows for further functionalization and modification, making it a versatile building block for the development of new molecules with potential applications in various fields, including materials science, agrochemistry, and environmental science.
Check Digit Verification of cas no
The CAS Registry Mumber 147663-00-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,7,6,6 and 3 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 147663-00:
(8*1)+(7*4)+(6*7)+(5*6)+(4*6)+(3*3)+(2*0)+(1*0)=141
141 % 10 = 1
So 147663-00-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO.ClH/c10-9-6-11-5-7-3-1-2-4-8(7)9;/h1-4,9H,5-6,10H2;1H
147663-00-1Relevant academic research and scientific papers
Reductive amination and resolution of isochroman-4-one
-
Paragraph 0005, (2017/08/27)
The invention discloses a method for preparation of isochroman-4-amine from isochroman-4-one through reductive amination and further dynamic resolution of isochroman-4-amine for preparation of R-isochroman-4-amine. The method provided by the invention has the advantages of simple operation, usage of easily available raw materials, good product yield, high optical purity of the products, etc.
2-AMINO- AND 2-THIO-SUBSTITUTED 1,3-DIAMINOPROPANES
-
Page/Page column 157, (2008/06/13)
Disclosed are compounds of the formula: where variables Q, Z, X, R15, R2, R3, and Rc are defined herein. Compounds disclosed herein are inhibitors of the beta-secretase enzyme and are therefore useful in the treatment of Alzheimer’s disease and other diseases characterized by deposition of A beta peptide in a mammal.
METHODS OF TREATMENT OF AMYLOIDOSIS USING BI-CYCLIC ASPARTYL PROTEASE INHIBITORS
-
Page/Page column 260-261, (2010/02/14)
The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
